top of page

BPC-157 is a 15 amino acid peptide based on a protein found in human gastric juice. It is one of the most researched recovery peptides, studied for tendons, ligaments, muscle, and the lining of the gut.

Woman stretching outdoors

Recovery Peptide

Injectable Vial

Adult athlete resting a sore knee

Every BPC-157 prescription we fill is compounded by a licensed 503A pharmacy, one patient at a time, and labeled with your directions. It comes as a 15 mg multi-dose vial for subcutaneous injection. It is also available paired with TB-500 as two separate vials, each given as its own injection. Your prescriber decides the dose and schedule that fit you.

​

Wondering if BPC-157 is right for you? Start an online consultation with a licensed physician. Your price includes the consultation, and if your prescription is approved, we compound your BPC-157 and our pharmacist follows up with next steps.

*Photos of models, not actual patients

*BPC-157 is a compounded product and has not been approved by the FDA. Not for resale.

For Your Doctor

BPC-157 3 mg/mL Injectable, 5 mL Vial (15 mg): $173

BPC-157 + TB-500 Pair, two separate vials: BPC-157 3 mg/mL, 5 mL (15 mg) and TB-500 2 mg/mL, 5 mL (10 mg): $242

Directions as written by the prescriber

The Use of Compounded BPC-157

 

Background

 

BPC stands for Body Protection Compound. BPC-157 is a stable 15 amino acid sequence taken from a larger protein found in human gastric juice. It was developed by researchers in Croatia in the early 1990s, and most of what is known about it comes from their animal work over the following three decades.

 

How It Is Thought to Work

 

Researchers believe BPC-157 supports repair by encouraging new blood vessel growth into injured tissue, interacting with the nitric oxide system, and increasing growth hormone receptors on tendon cells. These mechanisms come from lab and animal studies. They have not been confirmed in people.

 

What It Has Been Studied For

 

In animal models, BPC-157 has been studied for tendon and ligament injuries, muscle tears, tendon to bone healing, stomach ulcers, and inflammatory bowel conditions.

 

Human data is limited to small reports, including a retrospective look at patients with knee pain, and an early clinical trial in ulcerative colitis whose results were not published.

 

Safety and Side Effects

 

BPC-157 has not been through large human safety trials. Reported side effects are uncommon and mostly mild, such as redness at the injection site, nausea, or dizziness.

 

Because it may promote blood vessel growth, people with a history of cancer should discuss it with their prescriber first. BPC-157 is prohibited in tested sports.

 

Summary

 

BPC-157 has a long research history in animals and growing interest from patients and physicians. Human evidence is still early. A prescriber who knows your health history is the right person to decide if it fits your plan.

 

bottom of page